Beneficial Outcome of Losartan Therapy Depends on Type of <i>FBN1</i> Mutation in Marfan Syndrome
Romy Franken(Academic Medical Center), Gerard Pals(University Medical Center Groningen), Alexander W. den Hartog(Netherlands Heart Institute), Teodora Radonic(Vrije Universiteit Amsterdam), Aeilko H. Zwinderman(Amsterdam Neuroscience), Dimitra Micha(Amsterdam Neuroscience), Maarten P. van den Berg(Regions Hospital), Barbara J.M. Mulder(Amsterdam UMC Location University of Amsterdam), Hanne Meijers‐Heijboer(German Cancer Research Center), Maarten Groenink(Royal Brompton & Harefield NHS Foundation Trust), Alessandra Maugeri(Vrije Universiteit Amsterdam), Fleur S van Dijk(University Medical Center Groningen), Vivian de Waard(Amsterdam Neuroscience), Janneke Timmermans(University Medical Center Groningen), Arthur J. Scholte(Fondazione Toscana Gabriele Monasterio)
Cited by 165
Related Papers
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
The Athlete’s Heart
|Circulation|2000|1.1k